Weight-loss treatments are on the cusp of a revolution, and could benefit large numbers of Indians after the main patent ...

The U.S. Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmac ...

Elon Musk, 53, shared on Wednesday that he uses Mounjaro, a weight-loss medication, after previously endorsing similar drugs ...

On December 20th, 2024, the Court of Appeals for the Federal Circuit issued an important decision in Teva Branded ...

New Jersey-based pharmaceutical company UCB has sued to protect its patents for a Parkinson’s drug after an India-based ...

The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a ...

The ongoing shortage of liraglutide injection and other GLP-1 medications prompted the FDA to prioritize the generic drug applications for these medications in order to improve patient access.

Wegovy and Ozempic are weight loss drugs that promise to transform the treatment of obesity, heart disease and other chronic ...

The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), ...

Valued at a market cap of $14.8 billion, Viatris Inc. (VTRS) is a healthcare company that operates in four segments: ...

CEO's use of Eli Lilly's (LLY) weight loss drug Mounjaro over Novo Nordisk's (NVO) rival product, Ozempic. Read more here.

The industry’s intellectual property manipulations are stealing from your pockets—and limiting the benefits of the Biden ...